was advised to continue four-drug ATT (HRZE). Repeat sputum AFB stain was negative. As symptoms persisted, the patient was advised for CECT chest which revealed multiple enlarged conglomerated centrally necrotic lymph nodes in the right upper paratracheal, bilateral lower paratracheal, bilateral hilar, aortopulmonary window, prevascular and para-aortic regions, the largest one in the right paratracheal region measuring 4.2 cm × 2.7 cm × 2.5 cm. Multiple subcentimetric size soft-tissue density nodules are seen in bilateral lung parenchyma. A small patchy area of ground-glass opacity was noted in the right upper lobe abutting the mediastinal lymph nodes [ Figure 1 b, e, h and k]. There is a small tiny hypodense lesion in IV-A segment of the liver with multiple hypodensities in splenic parenchyma suggestive of infective granuloma. As compared to the previous CECT, there is an increase in the number of nodal stations and lung nodular lesions with hepatosplenic involvement. Endobronchial ultrasound was done, and fine-needle aspiration cytology (FNAC) was taken from the right paratracheal and left hilar lymph nodes. Pus aspirated was AFB smear positive, MTB detected high in GeneXpert and rifampicin resistance was not detected. Subsequent AFB culture was, however, negative. Hence, a paradoxical upgradation response was thought of and the patient was given oral prednisolone and the first-line ATT continued. The steroid was gradually tapered over 8 weeks. Repeat CT showed a decrease in number and size of mediastinal lymphadenopathy with interval resolution of lung parenchymal nodules [ Figure 1 c, f, i and l]. The patient completed first-line ATT and recovered without any further complications.
Case 2
A 63-year-old male, non-smoker, non-alcoholic, driver by profession, with a history of diabetes mellitus, hypertension and psoriasis presented with complaints of high-grade fever associated with a cough, chest pain and dyspnoea for 1 week. Chest X-ray was done, and it revealed an increased cardiothoracic ratio. Two-dimensional (2D) echo revealed moderate concentric left ventricular hypertrophy. The patient was started on conservative management with IV antipyretics, antibiotics and other supportive treatments. As there was no improvement, a CT thorax and abdomen was done which revealed loculated fluid density in the anterior mediastinum with enlarged partially necrotic lymph nodes and increased vascularity with a possibility of TB or neoplasia and bilateral pleural effusion present (left >right) [ Figure 2 a and d]. A CT-guided FNAC was done, and mediastinal fluid aspirated was sent for AFB stain and culture and found to be AFB stain He was on regular follow-up with improving symptoms. However, at 2 months post-ATT, the patient again presented with chest heaviness, shortness of breath, cough and fever. A repeat CT chest was done on an outpatient basis which upon comparison with the earlier CT showed an interval increase in size and extent of the mediastinal loculated collection; however, there was an interval resolution of pleural effusion [ Figure 2 b and e]. As the AFB culture sensitivity report was awaited, considering a possibility of multidrug-resistant TB moxifloxacin and amikacin were added to four-drug ATT. However, the patient continued to be symptomatic with persisting frequent episodes of nausea, vomiting, chest discomfort and worsening breathlessness, so he was admitted for further management. A repeat CT thorax and abdomen was done, and it revealed bilateral moderate pleural effusion (left > right) with underlying passive partial collapse, moderate to significant pericardial effusion with pericardial thickening and enhancement likely pericarditis, heterogeneous-enhancing inflammatory changes in anterior mediastinum prevascular space in retrosternal location-likely infective or inflammatory changes with no significant mediastinal adenopathy [ Figure 2 c and f]. The liver was found to be grossly enlarged with no evidence of focal lesion/intrahepatic biliary radical dilatation. 2D echo was repeated, and it showed early effusive constrictive pericarditis with mild pericardial effusion [ Figure 3 a]. Subsequently, his AFB culture sensitivity test revealed MTB sensitive to all first-line drugs. In view of documented sensitive MTB and history of regular intake of ATT by the patient, a possibility of paradoxical upgradation reaction was thought, and the patient was started on oral corticosteroid. In view of echo findings and significant symptoms, opinion was taken from a cardiologist and cardiothoracic surgeon, and the patient was advised pericardiectomy. However, the patient refused for the same, so the patient was discharged after stabilisation on oral steroids with a plan for surgery in case of further worsening. His clinical condition improved gradually, and steroids were tapered over time. Repeat echo revealed minimal pericardial effusion with no evidence of constrictive pericarditis [ Figure 3 b]. The patient recovered without any further complications after completing first-line ATT.
dIscussIon
Paradoxical reactions were first identified by Choremis et al. [1] Paradoxical reactions can be clinical or radiological. [2] Pornsuriyasak and Suwatanapongched proposed a diagnostic criteria which include (1) initial clinical/radiological improvement with adequate ATT, (2) paradoxical clinical/radiological deterioration, (3) no conditions interfering with efficacy of ATT should be present (compliance, malabsorption or side effects) and (4) absence of other explanations for deterioration. [3] Paradoxical reaction is common and may affect up to 25% of patients being treated for TB. [4] They have unpredictable timing, clinical course and severity. [5, 6] The time to onset is mostly from 28 to 50 days and could be 9 months also. [2] For paradoxical reaction to be diagnosed, the clinical or radiological worsening should occur at least 1 month of receiving ATT according to Carvalho et al. [7] The worsening of patient condition seen in 2 weeks to <1-month period might be attributed to delayed treatment response. [2] Evidence suggests that latency of paradoxical response is more in EPTB compared to PTB. Contributing factors or predictors of paradoxical upgradation reaction are young age, HIV-positive status, short duration of illness, high lymphocyte count, highly positive tuberculin skin sensitivity test, recipient of Vitamin D at start of therapy, AFB culture-positive diagnostic sample, disseminated TB and EPTB. [2, 3, [8] [9] [10] [11] [12] Paradoxical upgradation response is attributed to hypersensitivity to the tubercular proteins and cell wall products released by the dying mycobacteria in response to ATT. [5, 13] It is said that culture-positive patients have more potential for paradoxical upgradation response since they have a higher mycobacterial load. Moreover, enhanced Toll-like receptor signalling is responsible for paradoxical reactions in the patient supplemented with Vitamin D at the start of therapy. [12] The AFB stain of a repeat sample could be positive, but the AFB culture should be negative to label it as a paradoxical reaction. [3] Paradoxical reactions are more commonly seen as worsening of the original lesions as compared to the development of new lesions. However, in both our cases, we have development of new lesions. Central nervous system (CNS) is the common site of paradoxical reaction whether it may be worsening or development of new lesions. After CNS, new lesions may develop as new pleural effusion or new lymph nodes. [4] However, in our cases, one had development of new lesions in the liver and spleen and the other developed pericardial effusion. Paradoxical reaction presenting as a case of splenic rupture is also reported. [4] Usually, a paradoxical reaction is self-limited, but it can also lead to respiratory failure and death. [3, 5] Paradoxical response may reappear in one-third of patients after discontinuation of corticosteroids. [3] In case of treatment failure, corticosteroids will worsen the condition. [6] Hence, there is a need for a clinician to have a high index of suspicion for paradoxical reactions in non-HIV TB as they are not uncommon and should be aptly managed.
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